Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-05

Clinical Trial Update: Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating triptorelin in combination with radiation therapy after surgery for intermediate-risk stage III or stage IV prostate cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triptorelin (triptorelin)

Snippet

Sponsor: UNICANCER | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED